Leflunomide (Arava) in early rheumatoid arthritis
Objective. To assess efficacy and safety of leflunomide in the treatment of early rheumatoid arthritis (RA). Material and methods. 30 pts with RA aged 18 to 67 years were examined. 17 pts with disease duration less than 6 months (mean 3,6±2,6 months) were included in group 1 and 13 pts with disease...
Saved in:
Main Authors: | R V Balabanova, D E Karateev, R YKashevarov, E L Luchihina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2005-10-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/322 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leflunomide monotherapy in patients with early rheumatoid arthritis: Results of the Russian national Arava mono study
by: Rimma Mikhailovna Balabanova, et al.
Published: (2012-06-01) -
LEFLUNOMIDE IN RHEUMATOID ARTHRITIS: URGENT MATTERS OF PRACTICAL USE
by: Yuri Aleksandrovich Olyunin
Published: (2009-09-01) -
Efficiency and safety of leflunomide in rheumatoid arthritis: Results of a Russian observational multicenter of trial
by: R. M. Balabanova, et al.
Published: (2015-06-01) -
Leflunomide in disease modifying treatment of rheumatoid arthritis in elderly patients
by: N A Nikitina, et al.
Published: (2008-12-01) -
Combination therapy for rheumatoid arthritis with rituximab and leflunomide(preliminary results of the Russian ARBITR Registry)
by: Evgeniy L'vovich Nasonov, et al.
Published: (2011-02-01)